Meet with us
at the American Diabetes Association (ADA) Meeting in San Francisco, USA
June 6 - 10, 2008
and
at BIO 2008 in San Diego, USA
June 17 - 20, 2008
|
About Debiopharm GroupDebiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. We develop our products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing. We independently fund the worldwide development of all of our products while providing expertise in preclinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs. The sales turnover of our products through our licensees was in excess of $2.65 billion in 2007. |
News |